Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Capital Leases (2022 - 2025)

Rockwell Medical's Capital Leases history spans 7 years, with the latest figure at $304000.0 for Q4 2025.

  • For Q4 2025, Capital Leases fell 67.35% year-over-year to $304000.0; the TTM value through Dec 2025 reached $304000.0, down 67.35%, while the annual FY2025 figure was $304000.0, 67.35% down from the prior year.
  • Capital Leases reached $304000.0 in Q4 2025 per RMTI's latest filing, down from $423000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $2.1 million in Q4 2022 to a low of $304000.0 in Q4 2025.
  • Average Capital Leases over 4 years is $1.2 million, with a median of $1.2 million recorded in 2024.
  • Peak YoY movement for Capital Leases: dropped 26.72% in 2023, then tumbled 67.35% in 2025.
  • A 4-year view of Capital Leases shows it stood at $2.1 million in 2022, then dropped by 26.72% to $1.5 million in 2023, then tumbled by 39.15% to $931000.0 in 2024, then crashed by 67.35% to $304000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Capital Leases are $304000.0 (Q4 2025), $423000.0 (Q3 2025), and $614000.0 (Q2 2025).